Regeneron Hits 52-Week Highs as Q3 Adjusted EPS Jumps 70%
Regeneron’s Q3 adjusted EPS surged 70% to $20.07, topping estimates, as Dupixent growth and improved collaboration economics supported results.
Regeneron’s Q3 adjusted EPS surged 70% to $20.07, topping estimates, as Dupixent growth and improved collaboration economics supported results.